Clinical characteristics

Cognitively impaired group (n = 24)

Cognitively unimpaired group (n = 16)

F-value

P-value

Age

63.79 ± 8.05

62.19 ± 9.51

0.404

>0.05

Sex, % male

83%

76%

-

-

Weight

71.08 ± 6.05

69.50 ± 6.39

0.01

>0.05

Levadopa dose mg/d

531.67 ± 204.30

437.50 ± 230.03

0.35

>0.05

duration of disease

4.10 ± 1.37

2.71 ± 0.99

0.97

<0.01

UPDRSIII score

32 ± 2.78

21.31 ± 2.70

0.16

<0.05

Hoehn & Yahr staging

2.06 ± 0.71

1.84 ± 0.72

0.1

>0.05

MMSE score

20.08 ± 1.81

27.56 ± 1.59

0.43

<0.001

MoCA score

16.79 ± 1.79

25.19 ± 1.22

2.6

<0.001

ADL score

45.04 ± 6.10

50.13 ± 7.70

1.08

<0.05